AzcA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

280 results for “AzcA”

Trials

View all 241 →

Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy

First posted Aug 16, 2007

Pediatric ANCA Associated-vasculitis

500 participants · First posted May 20, 2022

Not yet recruiting

AZA+Lus VS AZA Monotherapy in HR-MDS

86 participants · First posted Apr 15, 2025

Drugs

View all 25 →

ASCA-101

ANCA-11

AICA ribonucleotide

C₉H₁₅N₄O₈P

Organizations

AZPA INTERNATIONAL

India

ARCA biopharma, Inc.

United States

News

View all 12 →

Scientists Map the Enzymatic Route That Builds 5-Azacytidine in Nature, Revealing a Rare Skeletal-Editing Reaction

FDA Updates Clinical Trial Guidance and ASCA Program

Amgen's Tavneos Enters Phase 3 Trial for Pediatric ANCA-Associated Vasculitis

Page 1 of 28